Arabic chatbot for breast cancer education
Part of Cancer, Skin clinical trials.
This study uses an Arabic-speaking AI chatbot to provide education and support to women with breast cancer. The goal is to help you better understand your diagnosis and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman diagnosed with breast cancer (any stage).
- You must be 18 years old or older.
- You must be able to read and communicate in Arabic.
- You must be willing to use an AI chatbot for the study.
- You must be able to give informed consent (understand and agree to take part).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an AI chatbot that helps patients understand radiation therapy for prostate cancer. If you are starting radiation treatment at Brigham and Women's Hospital, this chatbot may help answer your questions and support you through your care.
This trial tests a mobile app that uses artificial intelligence to help women with early-stage breast cancer manage symptoms during their first chemotherapy. The app is in Arabic and is designed to make it easier to report how you're feeling and get support.
This study is testing a new AI chatbot that gives support after breast cancer treatment. If you join, you'll chat with the bot on Line to help with your recovery.
This study is testing a chatbot that provides emotional support to adults recently diagnosed with cancer. It aims to help you manage stress and anxiety during early treatment.
This study tests a new computer-based education module created by artificial intelligence to help breast cancer patients understand their diagnosis and treatment options. The goal is to see if this tool helps patients feel more informed and prepared for their care.
This study tests a chatbot that sends text messages to help Black women aged 40-74 schedule breast cancer screenings. It aims to increase screening rates by providing information and reminders in a friendly, accessible way.
Hear when a new Breast Cancer Early Stage Breast Cancer (Stage 1-3) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.